Glenmark Pharma can test Rs 550-555: Gaba

16951 Investors following Glenmark. Share this News with them.

0

Like this story, share it with millions of investors on M3

Glenmark Pharma can test Rs 550-555: Gaba

Technical Analyst, Prakash Gaba is of the view that Glenmark Pharma can test Rs 550-555. At Rs 450, there is a strong base coming in. It’s a good entry point too and one can just hold on to the stock.

Post your opinion here

 

0

Tweet

Share on Tumblr

Excerpts from Your Stocks on CNBC-TV18 Watch the full show » RELATED NEWS Hold Glenmark Pharma: Madan Buy Glenmark Pharma: DSP Merrill Lynch Glenmark regains global R&D rights for diabetic drug Glenmark Pharma in poor health Glenmark to get back global rights to Melogliptin GRC 8200 ALSO READ See previous views by Prakash Gaba See what other Experts & Brokerages are saying about Glenmark See messages about Glenmark Glenmark BSE | NSE 28/05/12 Are Mutual Funds betting on Glenmark?

Technical Analyst, Prakash Gaba is of the view that Glenmark Pharma can test Rs 550-555.

Gaba told CNBC-TV18, "In Glenmark Pharma Rs 550 shouldn't be a problem. It's trying to find base, now it's around Rs 470 and at Rs 450, there is a strong base coming in. So there is a safe point to buy, it should go to around Rs 550 or Rs 555. It's a good entry point too and if you are holding just hold on to the stock."

Disclosure: Analyst doesn't hold the above stock.